Effective strategies to prevent cytomegalovirus disease after renal transplantation

Transplantation Proceedings

Volumn 32, Issue 7, 2000, Pages 1508-1509

  Chapman, J R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR; IMMUNOGLOBULIN G ANTIBODY; OKT 3; VALACICLOVIR;

ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 0033665008     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01570-0     Document Type: Article

References (8)

1. McCarth JM, Karim MA, Kreuger H, et al: Transplantation 55:1277, 1993
2. Ratnamohan VM, Chapman JR, Howse H, et al: Transplantation 66:877, 1998
3. Paya C: personal communication
4. Glowacki L, Smaill F: Transplant Proc 25:1408, 1993
5. Brennan D: International Congress of Nephrology, 1997
6. Merigan TC, Renlund DG, Keay S, et al: N Engl J Med 326:1182, 1992
7. Speich R, Thurnheer R, Gaspert A, et al: Transplantation 67:315, 1999
8. Nankivell BJ, Malouf MA, Russ GR, et al: Clin Transpl 12:270, 1998